A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymistaâ„¢ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis
Phase 2
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Dymistaâ„¢ Nasal SprayDrug: Placebo
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- Apotex Inc.
- Target Recruit Count
- 595
- Registration Number
- NCT02279563
A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnarisâ„¢ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Apotex Inc.
- Target Recruit Count
- 580
- Registration Number
- NCT02273817
A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2009-09-30
- Lead Sponsor
- Apotex Inc.
- Registration Number
- NCT00987233
- Locations
- 🇺🇸
Clinsys Clinical Research, Inc., Bedminster, New Jersey, United States
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
Phase 3
Completed
- Conditions
- Actinic Keratosis
- Interventions
- First Posted Date
- 2009-03-10
- Last Posted Date
- 2009-03-10
- Lead Sponsor
- Apotex Inc.
- Target Recruit Count
- 497
- Registration Number
- NCT00859105
© Copyright 2025. All Rights Reserved by MedPath